Aaron Sato - Twist Bioscience Chief Officer
| TWST Stock | USD 43.20 1.80 4.35% |
Insider
Aaron Sato is Chief Officer of Twist Bioscience Corp
| Address | 681 Gateway Boulevard, South San Francisco, CA, United States, 94080 |
| Phone | 800 719 0671 |
| Web | https://www.twistbioscience.com |
Twist Bioscience Management Efficiency
The company has return on total asset (ROA) of (0.1563) % which means that it has lost $0.1563 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.304) %, meaning that it created substantial loss on money invested by shareholders. Twist Bioscience's management efficiency ratios could be used to measure how well Twist Bioscience manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.3 in 2024. Return On Capital Employed is likely to drop to -0.29 in 2024. Non Current Liabilities Total is likely to gain to about 90.3 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 45.4 M in 2024.Similar Executives
| Showing other executives | INSIDER Age | ||
| Keeley Aleman | Waters | 47 | |
| Steve Kunszabo | DermTech | N/A | |
| Michael Howell | DermTech | N/A | |
| Belinda Hyde | Waters | 53 | |
| Susan Rataj | Agilent Technologies | 63 | |
| Ray Bassi | DermTech | N/A | |
| Georgeann Couchara | Danaher | 47 | |
| Kevin Kempskie | Waters | N/A | |
| Otis Brawley | Agilent Technologies | 61 | |
| John MD | DermTech | 58 | |
| Dan Welch | Waters | 58 | |
| Scott Ericksen | Illumina | 51 | |
| Carissa Rollins | Illumina | 54 | |
| Katharine Knobil | Agilent Technologies | 56 | |
| Jennifer Eilemberg | DermTech | N/A | |
| Michael Bell | Guardant Health | 55 | |
| Claudia Ibarra | DermTech | 62 | |
| Allison Ballmer | Agilent Technologies | N/A | |
| Alexander MD | Illumina | 47 | |
| Jiang Wei | Waters | N/A | |
| Pardis Sabeti | Danaher | 45 | |
Management Performance
| Return On Equity | -0.3 | ||||
| Return On Asset | -0.16 |
Twist Bioscience Corp Leadership Team
Elected by the shareholders, the Twist Bioscience's board of directors comprises two types of representatives: Twist Bioscience inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Twist. The board's role is to monitor Twist Bioscience's management team and ensure that shareholders' interests are well served. Twist Bioscience's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Twist Bioscience's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Emily Leproust, President CEO, Director | ||
| William Banyai, GM Development | ||
| Patrick Finn, Vice President of Sales and Marketing | ||
| Kevin Yankton, VP Officer | ||
| Chet Gandhi, Chief Officer | ||
| Siyuan Chen, Chief Officer | ||
| Aaron Sato, Chief Officer | ||
| Dennis Cho, General VP | ||
| James Thorburn, Chief Officer | ||
| Erin Smith, Sr Policy | ||
| Adam Laponis, Chief Officer | ||
| Paula Green, Vice President of Human Resources | ||
| Angela Bitting, Chief Affairs | ||
| Robert Werner, VP Officer |
Twist Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Twist Bioscience a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.3 | ||||
| Return On Asset | -0.16 | ||||
| Profit Margin | (0.69) % | ||||
| Operating Margin | (0.65) % | ||||
| Current Valuation | 2.31 B | ||||
| Shares Outstanding | 58.23 M | ||||
| Shares Owned By Insiders | 1.75 % | ||||
| Shares Owned By Institutions | 98.23 % | ||||
| Number Of Shares Shorted | 12.25 M | ||||
| Price To Book | 3.01 X |
Twist Bioscience Investors Sentiment
The influence of Twist Bioscience's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Twist. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Twist Bioscience's public news can be used to forecast risks associated with an investment in Twist. The trend in average sentiment can be used to explain how an investor holding Twist can time the market purely based on public headlines and social activities around Twist Bioscience Corp. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Twist Bioscience's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Twist Bioscience's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Twist Bioscience's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Twist Bioscience.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Twist Bioscience in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Twist Bioscience's short interest history, or implied volatility extrapolated from Twist Bioscience options trading.
Currently Active Assets on Macroaxis
When determining whether Twist Bioscience Corp is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Twist Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Twist Bioscience Corp Stock. Highlighted below are key reports to facilitate an investment decision about Twist Bioscience Corp Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Twist Bioscience Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Complementary Tools for Twist Stock analysis
When running Twist Bioscience's price analysis, check to measure Twist Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Twist Bioscience is operating at the current time. Most of Twist Bioscience's value examination focuses on studying past and present price action to predict the probability of Twist Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Twist Bioscience's price. Additionally, you may evaluate how the addition of Twist Bioscience to your portfolios can decrease your overall portfolio volatility.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |
Is Twist Bioscience's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Twist Bioscience. If investors know Twist will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Twist Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.36) | Revenue Per Share 4.834 | Quarterly Revenue Growth 0.251 | Return On Assets (0.16) | Return On Equity (0.30) |
The market value of Twist Bioscience Corp is measured differently than its book value, which is the value of Twist that is recorded on the company's balance sheet. Investors also form their own opinion of Twist Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Twist Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Twist Bioscience's market value can be influenced by many factors that don't directly affect Twist Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Twist Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Twist Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Twist Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.